Mirada Medical announced that it has been selected to deliver its advanced XD3 image review and analysis software to The University of Texas MD Anderson Cancer Center in Houston. Mirada's latest XD3 software release includes volumetric CT segmentation in addition to tools for CT/PET and MR/PET to facilitate both anatomical and functional response tracking. Mirada XD3 provides powerful tools and efficient workflows for quantification and tracking of findings in an unlimited number of studies for all major modalities including CT, MR, CT/PET and MR/PET.
"We are delighted that MD Anderson Cancer Center has chosen Mirada software." stated Dr. Timor Kadir, Chief Scientist at Mirada Medical. "With tools such as CT segmentation, auto-alignment, and built-in findings tracking, our latest release offers the power to handle the growing imaging volumes and complexity in trials."